An investor asked on the investor interaction platform: Hello, how are your company’s current preclinical service projects of traditional Chinese medicine? Has the recent national support for traditional Chinese medicine policies had a positive impact on these projects
Boji Medical Technology Co.Ltd(300404) (300404. SZ) said on the investor interaction platform on January 5 that the company’s preclinical traditional Chinese medicine project is steadily advancing. In addition to accepting the entrustment of customers, the company also has some innovative varieties of traditional Chinese medicine independently developed, and the company’s traditional Chinese medicine research remains ahead in key technologies. National policies support the development of traditional Chinese medicine. Under the background of continuous improvement of the standardization system of traditional Chinese medicine, the traditional Chinese medicine industry will usher in better development prospects.
(Daily Economic News)
